IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Eris Lifesciences Limited is an Pharmaceutical based company, located in Ahmedabad, Eris Lifesciences Limited IPO size was 1741.16 Cr. and was issued at 603.00 per share. The share of Eris Lifesciences Limited were listed at 601.05 per share and are currently trading at 1412.15 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
Eris Lifesciences operates in Pharmaceutical and Developer Manufacturer And Commercializer Of Branded Pharmaceutical Produ. The Issue is listed on MainBoard in Jun, 2017. Eris Lifesciences IPO size was 1741.16 Cr. with Issue price of 603.00 .
Merchant Banker(s) of Eris Lifesciences IPO: Axis Capital Limited , Citigroup Global Markets India Private Limited , Credit Suisse Securities (India) Private Limited
Eris Lifesciences IPO subscription was 3.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Eris Lifesciences IPO listed at a listing price of 601.05 against the offer price of 603.00.
The current market price of Eris Lifesciences is 1412.15.
Why Us?
